C50.82
Non-billableMalignant neoplasm of overlapping sites of breast, male
C50.82 is the ICD-10-CM code for Malignant neoplasm of overlapping sites of breast, male. It is a non-billable category code — use a more specific child code such as C50.821 for billing.
C00-D49 Neoplasms
What this means — in plain language
MedlinePlus · NIHAlthough breast cancer is much more common in women, men can get it too. It happens most often to men between the ages of 60 and 70. Breast lumps usually aren't cancer. However, most men with breast cancer have lumps. Other breast symptoms can include: Dimpled or puckered skin A red, scaly nipple or skin Fluid discharge Risk factors for male breast cancer include exposure to radiation, a family history of breast…
Read more about Male Breast Cancer at MedlinePlus ↗Source: U.S. National Library of Medicine (MedlinePlus). Informational only — not medical advice.
Medications indicated for this condition
FDA labeling- TestosteroneAndrogen [EPC]›
- DenosumabRANK Ligand Inhibitor [EPC]›
- Doxorubicin›
- MethotrexateFolate Analog Metabolic Inhibitor [EPC]›
- PaclitaxelMicrotubule Inhibitor [EPC]›
- Gemcitabine›
- TrastuzumabHER2/neu Receptor Antagonist [EPC]›
- CapecitabineNucleoside Metabolic Inhibitor [EPC]›
- DocetaxelMicrotubule Inhibitor [EPC]›
- Eribulin›
- estrogens, conjugated (USP)Estrogen [EPC]›
- FulvestrantEstrogen Receptor Antagonist [EPC]›
Drugs whose FDA labeling lists this condition's category among its indications. Informational only — not a treatment recommendation or medical advice.
Frequently asked questions
Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.
Look up another ICD-10 code or condition